The Hill | March 4, 2021
“I do think he risks overpromising,” said Larry Gostin, a Georgetown Law professor specializing in public health. “He underpromised on the number of vaccines at the beginning, and this may be an overpromise. We have a long way to go, to get from here to there, and there are a lot of barriers.”